HomeMy WebLinkAboutItem 3C - PresentationPage 1 of 5
•Multistate settlements with pharmaceutical distributors and manufacturers.
•Allowable Uses:
•Support for substance-use disorder facilities and improve infrastructure for
treatment.
•Address the needs of communities of color and vulnerable populations,
including those who are unhoused.
•Strengthen availability of Naloxone (NARCAN) or other FDA-approved
overdose reversal drugs.
•Support job creation programs to help connect those recovering from
substance use disorders with gainful employment and pathways to financial
stability.
Page 2 of 5
•New program
•Local rehabilitation center reported 75% of their population exited treatment
due to lack of funds, or insurance.
•City Staff encounters 1-2 homeless individuals weekly who would go to
rehabilitation if they could afford it.
•Only a few rehabilitation centers accept MediCal.
•Estimating 8 Re-entry Clients per year.
•Estimated cost of $5,000 each.
•Estimated Annual program cost $40,000
Page 3 of 5
•New Program
•Makes Narcan and other harm reduction items more readily available in vending
machines.
•The vending machines could also provide information to connect individuals to low
barrier assistance.
•Avoids stigma of requesting assistance for substance misuse
•Estimating cost of vending machine (refrigerated) $15,000.
•Two of vending machines estimated (emergency rooms, homeless service providers)
•Estimated Annual program cost $30,000
Page 4 of 5
•Becomes part of existing TBRA program
•Assists individuals in need undergoing rehabilitation.
•Provides supportive environment and reduces chances of relapse.
•Estimating 18 TBRA clients that utilize the Opioid Settlement funds per
year.
•Estimated cost of $8,000 each.
•Estimated Annual program cost $144,000
Page 5 of 5